122 related articles for article (PubMed ID: 12493785)
41. Detection of N526K-substituted penicillin-binding protein 3 conferring low-level mutational resistance to β-lactam antibiotics in Haemophilus influenzae by disc diffusion testing on Mueller-Hinton agar according to EUCAST guidelines.
Søndergaard A; Petersen MT; Fuursted K; Nørskov-Lauritsen N
J Antimicrob Chemother; 2012 Jun; 67(6):1401-4. PubMed ID: 22389455
[TBL] [Abstract][Full Text] [Related]
42. Activity of cephalosporin antibiotics against Haemophilus influenzae.
Philpott-Howard J; Williams JD
Scand J Infect Dis Suppl; 1983; 39():109-11. PubMed ID: 6606223
[TBL] [Abstract][Full Text] [Related]
43. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
Alou L; Giménez MJ; Sevillano D; Aguilar L; González N; Echeverría O; Torrico M; Coronel P; Prieto J
J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471
[TBL] [Abstract][Full Text] [Related]
44. In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs.
Schmitz FJ; Boos M; Mayer S; Verhoef J; Milatovic D; Fluit AC
J Antimicrob Chemother; 2002 Jan; 49(1):220-3. PubMed ID: 11751796
[No Abstract] [Full Text] [Related]
45. Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe.
Preston DA; Turik M
J Chemother; 1998 Jun; 10(3):195-202. PubMed ID: 9669643
[TBL] [Abstract][Full Text] [Related]
46. [Serotype distribution and drug resistance of
Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
[No Abstract] [Full Text] [Related]
47. Serotype distribution and beta-lactam resistance in Haemophilus influenzae isolated from patients with respiratory infections in Korea.
Bae S; Lee J; Kim E; Lee J; Yu J; Kang Y
J Microbiol; 2010 Feb; 48(1):84-8. PubMed ID: 20221734
[TBL] [Abstract][Full Text] [Related]
48. [Resistance of Haemophilus influenzae and Haemophilus parainfluenzae to beta-lactam antibiotics. Characterization of the beta-lactamases].
Tirado M; Baró MT; Hermida M; Morta M; Alia C; Roy C
Enferm Infecc Microbiol Clin; 1992; 10(6):355-9. PubMed ID: 1391019
[TBL] [Abstract][Full Text] [Related]
49. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Pottumarthy S; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
[TBL] [Abstract][Full Text] [Related]
50. Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan.
Hotomi M; Fujihara K; Billal DS; Suzuki K; Nishimura T; Baba S; Yamanaka N
Antimicrob Agents Chemother; 2007 Nov; 51(11):3969-76. PubMed ID: 17698631
[TBL] [Abstract][Full Text] [Related]
51. In vitro activity of loracarbef against TEM extended-spectrum beta-lactamase-producing Escherichia coli strains and its interaction with the enzymes.
Prinarakis EE; Tzouvelekis LS; Legakis NJ
Chemotherapy; 1998; 44(4):260-4. PubMed ID: 9681202
[TBL] [Abstract][Full Text] [Related]
52. Antimicrobial susceptibility of Haemophilus influenzae strains isolated from invasive disease in Italy.
Cerquetti M; Cardines R; Giufrè M; Mastrantonio P;
J Antimicrob Chemother; 2004 Dec; 54(6):1139-43. PubMed ID: 15486078
[TBL] [Abstract][Full Text] [Related]
53. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.
Hoban D; Felmingham D
J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():49-59. PubMed ID: 12239228
[TBL] [Abstract][Full Text] [Related]
54. Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 2001 May; 45(5):1585-8. PubMed ID: 11302835
[TBL] [Abstract][Full Text] [Related]
55. [Beta-lactamase-producing Haemophilus influenzae isolated in Portugal, 1989-1992].
Bajanca Lavado MP; Casin I; Vaz Pato MV
Pathol Biol (Paris); 1994 May; 42(5):481-6. PubMed ID: 7824318
[TBL] [Abstract][Full Text] [Related]
56. Macrolide susceptibility and beta-lactamase production among haemophilus influenzae isolates in the United States, 1996-1997.
Hogan PA; Sheehan DJ
Antimicrob Agents Chemother; 1998 Dec; 42(12):3313-4. PubMed ID: 9835536
[TBL] [Abstract][Full Text] [Related]
57. Investigation of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines.
Heelan JS; Chesney D; Guadagno G
J Clin Microbiol; 1992 Jul; 30(7):1674-7. PubMed ID: 1629320
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of Hemophilus type B systemic isolates for beta-lactamase and non-beta-lactamase mediated ampicillin resistance and for susceptibility to other antimicrobial agents.
Woolfrey BF; Lally RT; Ederer MN
Am J Clin Pathol; 1987 Sep; 88(3):361-5. PubMed ID: 3498359
[TBL] [Abstract][Full Text] [Related]
59. Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.
Bulger RR; Washington JA
Antimicrob Agents Chemother; 1980 Mar; 17(3):393-6. PubMed ID: 6448575
[TBL] [Abstract][Full Text] [Related]
60. In vitro antimicrobial activity of piperacillin and seven other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase producing strains.
Thornsberry C; Baker CN; Jones RN
J Antimicrob Chemother; 1979 Mar; 5(2):137-42. PubMed ID: 107152
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
